Colon cancer test data promising:
This article was originally published in Clinica
Matritech researchers have presented data on the NuMA blood test kit for colon cancer showing it to be sensitive at detecting early stage cancers. Tests were conducted on 1,200 blood specimens from a variety of patients with colon tumours, other tumours, benign diseases, risk factors for colon cancer and healthy patients.
You may also be interested in...
The first trial of the new Flash ultra-high dose radiation therapy with Varian Medical Systems’ ProBeam particle accelerator has begun. Agum Sharda, Varian’s senior director of Flash, says the technology could be a major advance for cancer patients.
The European public assessment report for Kaftrio shows that EU regulators had concerns about whether Vertex’s triple drug combination for cystic fibrosis represented a new treatment paradigm.
Swissmedic says its good manufacturing practice certificates remain valid for longer than companies might assume. Separately, it is giving companies more time to conduct nitrosamine-related risk evaluations.